- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03282968
Balance Training After Stroke With REWIRE (REWIRESI)
November 28, 2023 updated by: University Rehabilitation Institute, Republic of Slovenia
Balance Training With the Rehabilitative Wayout In Responsive Home Environments (REWIRE) System in Patients After Stroke
The study will include 20 patients after stroke, randomly assigned to the experimental and control group (10 each).
In both groups, the program with last for five days; walking and balance will be assessed before and after the program.
Both groups will receive regular neurophysiotherapy; in addition, the experimental group will exercise each day by playing REWIRE games, while the control group will perform standing balance exercises.
Study Overview
Detailed Description
Detailed inclusion and exclusion criteria are specified in the appropriate section.
Both groups will perform the additional exercises for 15 minutes daily.
In addition to the outcome measurement, informal feedback will be obtained from the patients and the therapists on the feasibility of the REWIRE system.
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Ljubljana, Slovenia, 1000
- University Rehabilitation Institute, Republic of Slovenia
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- first stroke
- first admission to inpatient rehabilitation
Exclusion Criteria:
- less than 25 points scored on the Mini-Mental State Examination
- inability to walk independently
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Device Feasibility
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental
Regular neurophysiotherapy plus REWIRE exercises
|
First, the patient will play the Fruit Catcher (weight transfer) game on the 3rd level for 3 minutes, followed by 3 minutes of rest.
Next, the patient will play the Horse Runner (squats) on the 3rd level for 3 minutes, followed by 3 minutes of rest.
In the end, the patient will play the Animal Hurdler (standing on one leg) on the 3rd level for 3 minutes.
During the games, the patient will be standing on the Wii Balance Board, holding to a firm support if necessary.
During the rest periods, the patients will be sitting.
A physiotherapist will be present throughout the exercise for safety and help if requested.
|
|
Active Comparator: Control
Regular neurophysiotherapy plus standing balance exercises
|
The patient will first practice balance transfer for 3 minutes (standing by a ladder, holding position on each leg for 3 seconds), followed by 3 minutes of rest.
Next, the patient will be performing squats for 3 minutes, followed by 3 minutes of rest.
In the end, the patient will practice alternatively lifting lower limbs (like stepping on a footstool) for 3 minutes.
During the rest periods, the patients will be sitting.
A physiotherapist will be present throughout the exercise for safety and help if requested.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in walking speed
Time Frame: Assessment one day before and one day after the program
|
Assessed using 10 Meter Walking Test
|
Assessment one day before and one day after the program
|
|
Change in dynamic balance
Time Frame: Assessment one day before and one day after the program
|
Assessed using Four Step Square Test
|
Assessment one day before and one day after the program
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in mobility
Time Frame: Assessment one day before and one day after the program
|
Assessed using Timed Up and Go test
|
Assessment one day before and one day after the program
|
|
Change in static standing balance
Time Frame: Assessment one day before and one day after the program
|
Assessed using Romberg test
|
Assessment one day before and one day after the program
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Imre Cikajlo, PhD, University Rehabilitation Institute, Rehabilitation of Slovenia
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 3, 2017
Primary Completion (Actual)
July 1, 2017
Study Completion (Actual)
March 31, 2018
Study Registration Dates
First Submitted
September 12, 2017
First Submitted That Met QC Criteria
September 12, 2017
First Posted (Actual)
September 14, 2017
Study Record Updates
Last Update Posted (Estimated)
December 5, 2023
Last Update Submitted That Met QC Criteria
November 28, 2023
Last Verified
November 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- URIS201704
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
Clinical Trials on REWIRE
-
Gary GoldfieldNot yet recruiting
-
Oregon Research Behavioral Intervention Strategies...National Institute on Drug Abuse (NIDA)CompletedAdolescent Substance UseUnited States
-
University of ZurichUniversity of Oxford; University of Padova; University Hospital, Zürich; Swiss... and other collaboratorsCompleted